PS

Poonam Singh

Active Director Director DIN 10271860
DIN 10271860 First appointment Sep 2023 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Sep 2023
Shareholding value Locked Premium profile

About Poonam Singh

Poonam Singh has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Affix Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10271860
Primary Designation Director
First Appointment 01 Sep 2023
Oldest Company Age 10 yrs

Current companies

Company Designation Appointment Founded Status
Director 01 Sep 2023 2015 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Affix Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Poonam Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Poonam Singh

Poonam Singh has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Affix Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Poonam Singh is associated with 1 company as Director.

Poonam Singh has expertise in General Business.

Poonam Singh has 2 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available